# FDA recall D-0007-2018

> **Boehringer Ingelheim Pharmaceuticals, Inc.** · Class III · drug recall initiated 2017-09-22.

## Product

Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01

## Reason for recall

Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.

## Distribution

CO, OH

## Key facts

- **Recall number:** D-0007-2018
- **Recalling firm:** Boehringer Ingelheim Pharmaceuticals, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-09-22
- **Report date:** 2017-10-18
- **Termination date:** 2018-04-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Danbury, CT, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0007-2018

## Citation

> AI Analytics. FDA recall D-0007-2018. Retrieved 2026-07-11 from https://api.ai-analytics.org/recall/D-0007-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*